Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2024 07:30 ET | Source: FACT.MR

Single Domain Antibody Platform Market to Reach US$ 86 Million by 2034, Expanding at a CAGR of 10.1% | Fact.MR Report

Rockville, MD, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Increasing investments in healthcare research and development are leading to the increased adoption of single domain antibody platforms due to their...
April 17, 2023 07:00 ET | Source: Oncotelic Therapeutics, Inc.

ONCOTELIC PROVIDES YE 2022 FINANCIAL RESULTS COMPARED TO YE 2021 PRODUCT DEVELOPMENT INITIATIVES AND CORPORATE UPDATE

AGOURA HILLS, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic”, “We” or the “Company”) (OTCQB:OTLC) is providing a summary of its financial results for the year...
April 27, 2022 09:30 ET | Source: Hope for HIE

ReAlta Life Sciences, Inc. Partners With Hope for HIE to Improve Neonatal Brain Injury Outcomes and Quality of Life

WEST BLOOMFIELD TOWNSHIP, Mich., April 27, 2022 (GLOBE NEWSWIRE) -- ReAlta Life Sciences, Inc. ("ReAlta") a clinical stage, rare disease company addressing life-threatening diseases through...
January 24, 2017 06:00 ET | Source: Neuronascent, Inc.

Neuronascent Announces Third US Patent Issued Covering Therapeutics for Neurodegenerative and Neuropsychiatric Disorders

CLARKSVILLE, MD--(Marketwired - January 24, 2017) - Neuronascent's U.S. Patent No. 9,539,261, which issued on January 10, 2017, claims methods of stimulating neurogenesis and/or inhibiting neuronal...